The Circadian Clock in Cancer Development and Therapy - Progress in Molecular Biology and Translational Science - page 273

281. Ramsey KM, Yoshino J, Brace CS, et al. Circadian clock feedback cycle through
NAMPT-mediated NAD þ biosynthesis. Science . 2009;324(5927):651-654.
282. Lamia KA, Sachdeva UM, DiTacchio L, et al. AMPK regulates the circadian clock by
cryptochrome phosphorylation and degradation. Science . 2009;326(5951):437-440.
283. Yin L, Wu N, Curtin JC, et al. Rev-erbalpha, a heme sensor that coordinates metabolic
and circadian pathways. Science . 2007;318(5857):1786-1789.
284. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol
Cell Biol . 1999;19(1):1-11.
285. Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator of glycolysis
and apoptosis. Cell . 2006;126(1):107-120.
286. Matoba S, Kang JG, Patino WD, et al. p53 regulates mitochondrial respiration. Science .
2006;312(5780):1650-1653.
287. Fernandez PC, Frank SR, Wang L, et al. Genomic targets of the human c-Myc protein.
Genes Dev . 2003;17(9):1115-1129.
288. Orian A, Grewal SS, Knoepfler PS, Edgar BA, Parkhurst SM, Eisenman RN. Genomic
binding and transcriptional regulation by the Drosophila Myc and Mnt transcription
factors. Cold Spring Harb Symp Quant Biol . 2005;70:299-307.
289. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B. A global transcriptional
regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA .
2003;100(14):8164-8169.
290. Cawley S, Bekiranov S, Ng HH, et al. Unbiased mapping of transcription factor bind-
ing sites along human chromosomes 21 and 22 points to widespread regulation of non-
coding RNAs. Cell . 2004;116(4):499-509.
291. Gao P, Tchernyshyov I, Chang TC, et al. c-Myc suppression of miR-23a/b enhances
mitochondrial glutaminase expression and glutamine metabolism. Nature . 2009;458
(7239):762-765.
292. Cam H, Balciunaite E, Blais A, et al. A common set of gene regulatory networks links
metabolism and growth inhibition. Mol Cell . 2004;16(3):399-411.
293. Morrish F, Giedt C, Hockenbery D. c-MYC apoptotic function is mediated by NRF-1
target genes. Genes Dev . 2003;17(2):240-255.
294. Hansson A, Hance N, Dufour E, et al. A switch in metabolism precedes increased mito-
chondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci
USA . 2004;101(9):3136-3141.
295. Vafa O, Wade M, Kern S, et al. c-Myc can induce DNA damage, increase reactive oxy-
gen species, and mitigate p53 function: a mechanism for oncogene-induced genetic
instability. Mol Cell . 2002;9(5):1031-1044.
296. Tanaka H, Matsumura I, Ezoe S, et al. E2F1 and c-Myc potentiate apoptosis through
inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination.
Mol Cell . 2002;9(5):1017-1029.
297. Sagun KC, Carcamo JM, Golde DW. Antioxidants prevent oxidative DNA damage
and cellular transformation elicited by the over-expression of c-MYC. Mutat Res .
2006;593(1-2):64-79.
298. Pelengaris S, Khan M, Evan G. c-MYC: more than just a matter of life and death. Nat
Rev Cancer . 2002;2(10):764-776.
299. Breckenridge DG, Shore GC. Regulation of apoptosis by E1A and Myc oncoproteins.
Crit Rev Eukaryot Gene Expr . 2000;10(3-4):273-280.
300. Blyth K, Terry A, O'Hara M, et al. Synergy between a human c-myc transgene and p53
null genotype in murine thymic lymphomas: contrasting effects of homozygous and
heterozygous p53 loss. Oncogene . 1995;10(9):1717-1723.
301. Elson A, Deng C, Campos-Torres J, Donehower LA, Leder P. The MMTV/c-myc
transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mam-
mary carcinomas in transgenic mice. Oncogene . 1995;11(1):181-190.